{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-23-146927","form_type":"8-K","ticker":null,"cik":"0001841873","company_name":"Khosla Ventures Acquisition Co.","filed_at":"2023-05-17T23:59:59+00:00","discovered_at":"2026-05-14T18:03:41.128231+00:00","generated_at":"2026-06-14T22:37:58.563762+00:00","sec_items":["3.01"],"event_type":"regulatory","sentiment":"negative","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"high","headline":"Khosla Ventures Acquisition receives Nasdaq non-compliance notice for compensation committee composition","bullets":["On May 9, 2023, Nasdaq notified KVSA that it violates Listing Rule 5605 because director resignation left Compensation Committee with one member.","Cure period expires on earlier of next annual stockholders' meeting or March 7, 2024; if meeting before Sept 5, 2023, then by Sept 5, 2023.","Company must submit evidence of compliance by the cure deadline; states it expects to comply within the cure period.","Non-compliance follows prior disclosed resignation of director Derek Anthony West from board and Compensation Committee."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-23-146927","json":"https://secwatch.observer/filing/0001193125-23-146927.json","markdown":"https://secwatch.observer/filing/0001193125-23-146927.md","text":"https://secwatch.observer/filing/0001193125-23-146927.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1841873/000119312523146927/0001193125-23-146927-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1841873/000119312523146927/d491259d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-14T22:37:58.563762+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"bbdbf2503984bb39e265a30e83f3be27129b2821","claim":"Khosla Ventures Acquisition Co. received a nasdaq deficiency notice notice regarding board independence (rules 5605, 5605(d)(4)).","evidence_excerpt":"May 9, 2023, Khosla Ventures Acquisition Co. (the “Company”) received a letter (the “Nasdaq Letter”) from the Listing Qualifications staff of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that, as a result of the resignation of Derek Anthony West, as previously disclosed, from the Company’s board of directors and its Compensation Committee, the Company is not in compliance with Nasdaq Listing Rule 5605, which requires that the Company’s Compensation Committee be comprised of at least two directors, all of whom are independent directors as defined by Nasdaq rules. The Nasdaq Lett","evidence_source":"SEC 8-K Item 3.01","evidence_url":"https://www.sec.gov/Archives/edgar/data/1841873/000119312523146927/0001193125-23-146927-index.htm","confidence":0.9,"family_label":"Listing & Compliance Notices","details":[{"label":"Exchange","value":"nasdaq"},{"label":"Notice","value":"deficiency notice"},{"label":"Deficiency","value":"board independence"},{"label":"Rules","value":"5605, 5605(d)(4)"}],"fact_type":"exchange_compliance_notice"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}